(SYNSAM) Synsam - Ratings and Ratios
Lenses, Frames, Sunglasses, Contact Lenses, Hearing Aids
SYNSAM EPS (Earnings per Share)
SYNSAM Revenue
Description: SYNSAM Synsam
Synsam AB operates in the optical retail and eye health sector in the Nordic Region, offering a range of products including lenses, frames, sunglasses, and contact lenses, as well as services like eye health services, hearing tests, and lifestyle subscriptions. The company has a significant presence in the region, with operations in Sweden, Denmark, Norway, Iceland, Faroe Islands, and Finland through various brands.
To evaluate the companys performance, we can look at key performance indicators (KPIs) such as revenue growth, same-store sales growth, and gross margin. A strong brand presence and diversified product offerings can contribute to revenue growth. Additionally, the companys e-commerce capabilities and omnichannel retail strategy can help drive sales and improve customer engagement. With a market capitalization of 8.28B SEK, Synsam AB is a significant player in the Nordic optical retail market.
From a financial perspective, the companys return on equity (RoE) of 15.86% indicates a relatively strong ability to generate profits from shareholder equity. The price-to-earnings (P/E) ratio of 21.22 suggests that the stock may be fairly valued, although this depends on various factors including industry benchmarks and growth expectations. To further assess the companys prospects, we can examine metrics such as operating margin, inventory turnover, and customer acquisition costs.
Considering the competitive landscape, Synsam ABs market share, brand recognition, and ability to adapt to changing consumer behaviors will be crucial in driving future growth. The companys strategic focus on expanding its e-commerce capabilities and enhancing customer experience through services like personal style advice and online eye examinations can help differentiate it from competitors.
SYNSAM Stock Overview
| Market Cap in USD | 832m |
| Sub-Industry | Life Sciences Tools & Services |
| IPO / Inception |
SYNSAM Stock Ratings
| Growth Rating | 31.4% |
| Fundamental | 70.6% |
| Dividend Rating | 52.5% |
| Return 12m vs S&P 500 | 7.62% |
| Analyst Rating | - |
SYNSAM Dividends
| Dividend Yield 12m | 3.43% |
| Yield on Cost 5y | 3.84% |
| Annual Growth 5y | 1.92% |
| Payout Consistency | 98.8% |
| Payout Ratio | 116.1% |
SYNSAM Growth Ratios
| Growth Correlation 3m | 51.3% |
| Growth Correlation 12m | 64% |
| Growth Correlation 5y | -18.3% |
| CAGR 5y | 6.21% |
| CAGR/Max DD 5y | 0.12 |
| Sharpe Ratio 12m | 0.67 |
| Alpha | 15.23 |
| Beta | 0.454 |
| Volatility | 33.54% |
| Current Volume | 938.6k |
| Average Volume 20d | 162k |
| Stop Loss | 57.2 (-3.1%) |
| Signal | 1.64 |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (397.0m TTM) > 0 and > 6% of Revenue (6% = 397.3m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA -2.72pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 0.39% (prev -9.34%; Δ 9.73pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 1.02b > Net Income 397.0m (YES >=105%, WARN >=100%) |
| Net Debt (2.94b) to EBITDA (1.62b) ratio: 1.81 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.01 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (145.5m) change vs 12m ago -1.54% (target <= -2.0% for YES) |
| Gross Margin 59.40% (prev 58.84%; Δ 0.56pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 80.39% (prev 72.42%; Δ 7.97pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.35 (EBITDA TTM 1.62b / Interest Expense TTM 615.0m) >= 6 (WARN >= 3) |
Altman Z'' -0.37
| (A) 0.00 = (Total Current Assets 2.07b - Total Current Liabilities 2.04b) / Total Assets 8.16b |
| (B) -0.23 = Retained Earnings (Balance) -1.86b / Total Assets 8.16b |
| (C) 0.10 = EBIT TTM 832.0m / Avg Total Assets 8.24b |
| (D) -0.31 = Book Value of Equity -1.75b / Total Liabilities 5.69b |
| Total Rating: -0.37 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 70.61
| 1. Piotroski 4.50pt = -0.50 |
| 2. FCF Yield 6.03% = 3.01 |
| 3. FCF Margin 9.50% = 2.38 |
| 4. Debt/Equity 1.23 = 1.79 |
| 5. Debt/Ebitda 1.88 = 0.24 |
| 6. ROIC - WACC 5.60% = 7.01 |
| 7. RoE 15.86% = 1.32 |
| 8. Rev. Trend 85.82% = 4.29 |
| 9. Rev. CAGR 7.53% = 0.94 |
| 10. EPS Trend 19.57% = 0.49 |
| 11. EPS CAGR -2.80% = -0.35 |
What is the price of SYNSAM shares?
Over the past week, the price has changed by +4.06%, over one month by +14.56%, over three months by +20.04% and over the past year by +25.88%.
Is Synsam a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SYNSAM is around 56.01 SEK . This means that SYNSAM is currently overvalued and has a potential downside of -5.07%.
Is SYNSAM a buy, sell or hold?
What are the forecasts/targets for the SYNSAM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 68 | 15.3% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 61.4 | 4% |
SYNSAM Fundamental Data Overview
Market Cap SEK = 7.92b (7.92b SEK * 1.0 SEK.SEK)
CCE Cash And Equivalents = 533.0m SEK (Cash And Short Term Investments, last quarter)
P/E Trailing = 20.2963
P/S = 1.1959
P/B = 3.2523
Beta = 0.478
Revenue TTM = 6.62b SEK
EBIT TTM = 832.0m SEK
EBITDA TTM = 1.62b SEK
Long Term Debt = 2.67b SEK (from longTermDebt, last quarter)
Short Term Debt = 376.0m SEK (from shortTermDebt, last quarter)
Debt = 3.05b SEK (Calculated: Short Term 376.0m + Long Term 2.67b)
Net Debt = 2.94b SEK (from netDebt column, last quarter)
Enterprise Value = 10.43b SEK (7.92b + Debt 3.05b - CCE 533.0m)
Interest Coverage Ratio = 1.35 (Ebit TTM 832.0m / Interest Expense TTM 615.0m)
FCF Yield = 6.03% (FCF TTM 629.0m / Enterprise Value 10.43b)
FCF Margin = 9.50% (FCF TTM 629.0m / Revenue TTM 6.62b)
Net Margin = 6.00% (Net Income TTM 397.0m / Revenue TTM 6.62b)
Gross Margin = 59.40% ((Revenue TTM 6.62b - Cost of Revenue TTM 2.69b) / Revenue TTM)
Tobins Q-Ratio = -5.96 (set to none) (Enterprise Value 10.43b / Book Value Of Equity -1.75b)
Interest Expense / Debt = 4.79% (Interest Expense 146.0m / Debt 3.05b)
Taxrate = 25.76% (from yearly Income Tax Expense: 127.0m / 493.0m)
NOPAT = 617.7m (EBIT 832.0m * (1 - 25.76%))
Current Ratio = 1.01 (Total Current Assets 2.07b / Total Current Liabilities 2.04b)
Debt / Equity = 1.23 (Debt 3.05b / last Quarter total Stockholder Equity 2.48b)
Debt / EBITDA = 1.88 (Net Debt 2.94b / EBITDA 1.62b)
Debt / FCF = 4.85 (Debt 3.05b / FCF TTM 629.0m)
Total Stockholder Equity = 2.50b (last 4 quarters mean)
RoA = 4.86% (Net Income 397.0m, Total Assets 8.16b )
RoE = 15.86% (Net Income TTM 397.0m / Total Stockholder Equity 2.50b)
RoCE = 16.07% (Ebit 832.0m / (Equity 2.50b + L.T.Debt 2.67b))
RoIC = 12.15% (NOPAT 617.7m / Invested Capital 5.09b)
WACC = 6.54% (E(7.92b)/V(10.97b) * Re(7.69%)) + (D(3.05b)/V(10.97b) * Rd(4.79%) * (1-Tc(0.26)))
Shares Correlation 5-Years: 0.0 | Cagr: 3.80%
Discount Rate = 7.69% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 80.97% ; FCFE base≈723.8m ; Y1≈863.7m ; Y5≈1.36b
Fair Price DCF = 161.5 (DCF Value 23.34b / Shares Outstanding 144.5m; 5y FCF grow 20.61% → 3.0% )
Revenue Correlation: 85.82 | Revenue CAGR: 7.53%
Rev Growth-of-Growth: 0.98
EPS Correlation: 19.57 | EPS CAGR: -2.80%
EPS Growth-of-Growth: -6.15